Insider Trading activities of Eiger Biopharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eiger Biopharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Eiger Biopharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Eiger Biopharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is EIGR. The reporting company's CIK number is 1305253.
The total value of stock buying since 2005 is $14,296,105.
The total value of stock sales since 2005 is $9,779,181.
The total value of stock option exercises since 2005 is $1,162,530.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Eiger Biopharmaceuticals, Inc. (EIGR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-12 5,000 $56,300 0 $0 0 $0
2018-11 19,000 $188,387 0 $0 0 $0
2018-10 0 $0 237,265 $2,855,721 0 $0
2018-04 0 $0 4,000 $40,000 4,000 $8,240
2017-09 15,000 $142,950 0 $0 0 $0
2016-11 15,460 $196,884 0 $0 0 $0
2016-08 192,187 $3,073,585 0 $0 0 $0
2016-06 3,750 $77,210 0 $0 0 $0
2016-05 1,245 $24,652 0 $0 0 $0
2015-04 0 $0 63,387 $1,150,895 63,387 $273,756
2015-03 0 $0 79,408 $1,881,135 79,408 $392,124
2015-02 0 $0 69,708 $1,114,135 69,708 $291,114
2015-01 0 $0 79,079 $1,408,904 79,079 $88,568
2014-12 0 $0 79,079 $1,118,331 79,079 $88,568
2014-11 0 $0 18,000 $210,060 18,000 $20,160
2014-02 1,309,461 $10,475,688 0 $0 0 $0
2001-11 6,000 $60,449 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Eiger Biopharmaceuticals, Inc. insiders (EIGR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-12-06 Dietz Thomas John (Director) Buy 5,000 11.26 56,300
2018-11-29 Mayer Eldon C. Iii (Director) Buy 4,000 10.21 40,840
2018-11-27 Mayer Eldon C. Iii (Director) Buy 7,500 9.92 74,407
2018-11-26 Mayer Eldon C. Iii (Director) Buy 7,500 9.75 73,140
2018-10-18 Nasr Khaled (10% Owner) Sale 237,265 12.04 2,855,721
2018-04-02 Quan Joanne (Chief Medical Officer) Sale 4,000 10.00 40,000
2018-04-02 Quan Joanne (Chief Medical Officer) Option Ex 4,000 2.06 8,240
2017-09-01 Glenn Jeffrey S (Director) Buy 15,000 9.53 142,950
2016-11-18 Glenn Jeffrey S (Director) Buy 460 12.90 5,934
2016-11-17 Glenn Jeffrey S (Director) Buy 15,000 12.73 190,950
2016-08-18 Cory David A (President and CEO) Buy 1,562 15.70 24,523
2016-08-18 Shaffer James P (Chief Business Officer) Buy 3,125 15.70 49,062
2016-08-18 Vivo Ventures Vi Affiilates Fund, L.p. (10% Owner) Buy 187,500 16.00 3,000,000
2016-06-22 Welch James H (Chief Financial Officer) Buy 500 19.79 9,897
2016-06-20 Welch James H (Chief Financial Officer) Buy 2,000 19.80 39,592
2016-06-13 Shaffer James P (Chief Business Officer) Buy 1,250 22.18 27,721
2016-05-23 Shaffer James P (Chief Business Officer) Buy 745 19.99 14,892
2016-05-19 Shaffer James P (Chief Business Officer) Buy 500 19.52 9,760
2015-04-06 Zsebo Krisztina M (Chief Executive Officer) Sale 47,931 18.30 877,137
2015-04-06 Zsebo Krisztina M (Chief Executive Officer) Option Ex 47,931 4.56 218,565
2015-04-02 Laba Rebecque J (VP, Corporate Operations) Sale 11,012 17.14 188,745
2015-04-02 Laba Rebecque J (VP, Corporate Operations) Option Ex 11,012 4.56 50,214
2015-04-01 Takeya Ryan K (VP, Manufacturing) Sale 4,444 19.13 85,013
2015-04-01 Takeya Ryan K (VP, Manufacturing) Option Ex 4,444 1.12 4,977
2015-03-09 Zsebo Krisztina M (Chief Executive Officer) Sale 47,931 24.76 1,186,771
2015-03-09 Zsebo Krisztina M (Chief Executive Officer) Option Ex 47,931 4.56 218,565
2015-03-06 Laba Rebecque J (VP, Corporate Operations) Sale 14,000 22.89 320,390
2015-03-06 Laba Rebecque J (VP, Corporate Operations) Option Ex 14,000 4.56 63,839
2015-03-06 Honig Peter (Director) Sale 5,000 25.00 125,000
2015-03-06 Honig Peter (Director) Option Ex 5,000 9.58 47,900
2015-03-05 Honig Peter (Director) Sale 4,700 22.39 105,256
2015-03-05 Honig Peter (Director) Option Ex 4,700 11.30 53,110
2015-03-02 Takeya Ryan K (VP, Manufacturing) Sale 7,777 18.48 143,718
2015-03-02 Takeya Ryan K (VP, Manufacturing) Option Ex 7,777 1.12 8,710
2015-02-09 Zsebo Krisztina M (Chief Executive Officer) Sale 47,931 15.89 761,863
2015-02-09 Zsebo Krisztina M (Chief Executive Officer) Option Ex 47,931 4.56 218,565
2015-02-06 Laba Rebecque J (VP, Corporate Operations) Sale 14,000 16.08 225,119
2015-02-06 Laba Rebecque J (VP, Corporate Operations) Option Ex 14,000 4.56 63,839
2015-02-02 Takeya Ryan K (VP, Manufacturing) Sale 7,777 16.35 127,153
2015-02-02 Takeya Ryan K (VP, Manufacturing) Option Ex 7,777 1.12 8,710
2015-01-09 Rudy Jeffrey J (VP, Clinical Operations) Sale 10,000 18.51 185,100
2015-01-09 Rudy Jeffrey J (VP, Clinical Operations) Option Ex 10,000 1.12 11,200
2015-01-07 Laba Rebecque J (VP, Corporate Operations) Sale 20,000 17.30 346,000
2015-01-07 Laba Rebecque J (VP, Corporate Operations) Option Ex 20,000 1.12 22,400
2015-01-06 Zsebo Krisztina M (Chief Executive Officer) Sale 41,302 17.51 723,198
2015-01-06 Zsebo Krisztina M (Chief Executive Officer) Option Ex 41,302 1.12 46,258
2015-01-02 Takeya Ryan K (VP, Manufacturing) Sale 7,777 19.88 154,606
2015-01-02 Takeya Ryan K (VP, Manufacturing) Option Ex 7,777 1.12 8,710
2014-12-09 Rudy Jeffrey J (VP, Clinical Operations) Sale 10,000 15.00 150,000
2014-12-09 Rudy Jeffrey J (VP, Clinical Operations) Option Ex 10,000 1.12 11,200
2014-12-09 Zsebo Krisztina M (Chief Executive Officer) Sale 41,302 15.00 619,530
2014-12-09 Zsebo Krisztina M (Chief Executive Officer) Option Ex 41,302 1.12 46,258
2014-12-05 Laba Rebecque J (VP, Finance and Administration) Sale 20,000 12.77 255,400
2014-12-05 Laba Rebecque J (VP, Finance and Administration) Option Ex 20,000 1.12 22,400
2014-12-01 Takeya Ryan K (VP, Manufacturing) Sale 7,777 12.01 93,401
2014-12-01 Takeya Ryan K (VP, Manufacturing) Option Ex 7,777 1.12 8,710
2014-11-14 Rudy Jeffrey J (VP, Clinical Operations) Sale 18,000 11.67 210,060
2014-11-14 Rudy Jeffrey J (VP, Clinical Operations) Option Ex 18,000 1.12 20,160
2014-02-04 Funder Joshua (Director) Buy 227,261 8.00 1,818,088
2014-02-04 Lundbeckfond Invest A/s (10% Owner) Buy 182,681 8.00 1,461,448
2014-02-04 Kordel Johan (Director) Buy 182,681 8.00 1,461,448
2014-02-04 Wiklund Fredrik (VP Corp Dvlpmnt & Invs Rltns) Buy 20,000 8.00 160,000
2014-02-04 Enterprise Partners Management Llc (10% Owner) Buy 133,083 8.00 1,064,664
2014-02-04 Foley Todd (Director) Buy 111,608 8.00 892,864
2014-02-04 Narachi Michael (Director) Buy 62,500 8.00 500,000
2014-02-04 Novartis Bioventures Ltd (10% Owner) Buy 162,386 8.00 1,299,088
2014-02-04 Pfizer Inc (10% Owner) Buy 227,261 8.00 1,818,088
2001-11-28 Mayer Eldon C. Iii (Director) Buy 6,000 10.07 60,449

Insider trading activities including stock purchases, stock sales, and option exercises of EIGR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Eiger Biopharmaceuticals, Inc. (symbol EIGR, CIK number 1305253) see the Securities and Exchange Commission (SEC) website.